机构:[1]Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, No. 225, Changhai Road, Shanghai 200438, China[2]Department of Clinical Medicine, Second Military Medical University, Shanghai, China[3]Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, China[4]Department of Surgery, Wexner Medical Center, Ohio State University, Columbus, OH, USA[5]Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fuzhou, Fujian, China[6]Department of Hepatobiliary Surgery, Pu’er People’s Hospital, Pu’er, Yunnan, China[7]The First Department of General Surgery, The Fourth Hospital of Harbin, Harbin, Heilongjiang, China[8]Department of General Surgery, Liuyang People’s Hospital, Liuyang, Hunan, China[9]Department of General Surgery, Ziyang First People’s Hospital, Ziyang, Sichuan, China
The incidence of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. Higher perioperative risks may be anticipated due to underlying steatohepatitis, while long-term outcomes after liver resection are unknown. We sought to investigate outcomes after liver resection for NAFLD-HCC versus hepatitis B virus (HBV)-HCC using propensity score matching (PSM).Consecutive patients who underwent liver resection for HCC between 2003 and 2014 were identified from a multicenter database. Patients with NAFLD-HCC were matched one-to-one to patients with HBV-HCC.Among 1483 patients identified, 96 (6.5%) had NAFLD-HCC and 1387 (93.5%) had HBV-HCC. Patients with NAFLD-HCC were older (median age 57 vs. 50 years), more often overweight (50.0% vs. 37.5%), less often to have cirrhosis (30.2% vs. 72.5%) and liver dysfunction (Child-Pugh B: 4.2% vs. 10.7%), had larger tumor size (median 7.2 vs. 6.2 cm) yet had better tumor differentiation (27.1% vs. 17.6%) compared with patients with HBV-HCC (all P < 0.05). Perioperative mortality and morbidity were comparable between the two groups (1.0% vs. 1.4% and 20.8% vs. 23.2%, both P > 0.05). No differences were noted in median OS and RFS among patient with NAFLD-HCC versus HBV-HCC before or after PSM.While patients with NAFLD-HCC had different clinical characteristics than patients with HBV-HCC, liver resection resulted in similar perioperative outcomes and comparable OS and RFS among patients with NAFLD-HCC and HBV-HCC.
基金:
National Natural Science Foundation of China (No. 81472284 and 81672699), and
Shanghai Pujiang Program (No. 16PJD004).
第一作者机构:[1]Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, No. 225, Changhai Road, Shanghai 200438, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yang Tian,Hu Lun-Yang,Li Zhen-Li,et al.Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC[J].JOURNAL OF GASTROINTESTINAL SURGERY.2020,24(2):320-329.doi:10.1007/s11605-018-04071-2.
APA:
Yang Tian,Hu Lun-Yang,Li Zhen-Li,Liu Kai,Wu Han...&Shen Feng.(2020).Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.JOURNAL OF GASTROINTESTINAL SURGERY,24,(2)
MLA:
Yang Tian,et al."Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC".JOURNAL OF GASTROINTESTINAL SURGERY 24..2(2020):320-329